Drug Repurposing for Emerging Infectious Diseases and Cancer (PDF)

,the third highest civilian award by the Government of India in 2009 for his contributions to the cause of Education. He has chaired /delivered lectures at the national and international conferences/symposia/workshops.



Dr. Sobti, an active researcher, is also steadfastly committed to the popularization of science in the community through popular lectures and community engagement programs.



Dr Sunil Lal is a PhD from the Georgia Institute of Technology, Atlanta, USA in Microbial Genetics (1989) following which he joined the faculty at California Institute of Technology, Pasadena (1994). Following this, Prof. Lal joined the ICGEB (International Center for Genetic Engineering and Biotechnology) of the United Nations at New Delhi, India where he served as an International Research Scientist for 21 years. In 2014 Prof Lal joined the School of Science, Monash University, Malaysia where he is currently a Professor of Microbiology and leads an active research group on Systems Virology. Prof. Sunil is internationally well known for his research work in the field of RNA viruses including SARS Coronaviruses, Influenza A virus and Hepatitis E virus. He has been a visiting scientist to Universiti Malaysia Sarawak, National University of Singapore, Karolinska Institute and the Centers for Disease Control (CDC) Atlanta. Prof. Sunil has won many prestigious international awards including the Hind Rattan (highest civilian honor from Govt. of India), and has been the regional representative for the American Society for Microbiology for 9 years besides being an Elected Fellow of the National Academy of Sciences (India). Prof. Sunil is on the editorial board of International Journals and is actively involved in peer-reviewing for some of the top-tier scientific journals. Prof. Sunil has over 200 publications in top international scientific journals and has published four international books on emerging viral diseases.



Professor Ramesh K. Goyal, is the Vice Chancellor of, Delhi Pharmaceutical Sciences and Research University, New Delhi. He was earlier the Vice-Chancellor of the Maharaja Sayajirao University of Baroda, Executive Director (Research & strategies) at V ClinBio Labs., Sri Ramachandra Medical Center University, Chennai, Director (Pharmacology and Clinical Research) at NMIMS University, Mumbai; Director ISF College of Pharmacy, Moga, Punjab and Professor at L. M. College of Pharmacy, Ahmedabad. He has been the Visiting Scientist and Visiting professor at the University of British Columbia, Vancouver, BC and Institute of Cardiovascular Sciences, Winnipeg, Canada. In 2019 he was conferred with the Honorary Professorship at Stavropol State Medical University, Russia and recently appointed as the Distinguished Professor at USCI University, Kula Lumpur, Malaysia. His research interest is development of newer drugs for cardiovascular and metabolic disorders through phyto-pharmaceuticals. Recently he has come up with an herbal formulation specifically targeting ACE-2 of SARC-CoV-2 virus. Dr Goyal got three patents awarded, 6 under consideration, 42 books and book chapters, over 350 full papers articles published in National and International journals. He is the recipient of 74 National & International Awards. He is the Fellow of eight professional bodies (FIPS, FIACS, FAMS, FIC, FICN, FNASc. FSCH, FIVSPT). He has been chairman/member of prestigious national and international bodies.